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Abstract 38 
Core and peripheral body temperatures are affected by changes in reproductive 39 
hormones during the menstrual cycle. Women worldwide use the basal body 40 
temperature (BBT) method to aid and prevent conception. However, prior research 41 
suggests taking one’s daily temperature can prove inconvenient and subject to 42 
environmental factors. We investigate whether a more automatic, non-invasive 43 
temperature measurement system can detect changes in temperature across the 44 
menstrual cycle. We examined how wrist-skin temperature (WST), measured with 45 
wearable sensors, correlates with urinary tests of ovulation and may serve as a new 46 
method of fertility tracking. One hundred and thirty-six eumenorrheic, non-pregnant 47 
women participated in an observational study. Participants wore WST biosensors 48 
during sleep and reported their daily activities. An at-home luteinizing hormone test 49 
was used to confirm ovulation. WST was recorded across 437 cycles (mean 50 
cycles/participant=3.21, S.D.=2.25). We tested the relationship between the fertile 51 
window and WST temperature shifts, using the BBT three-over-six rule. A sustained 52 
three-day temperature shift was observed in 357/437 cycles (82%), with the lowest 53 
cycle temperature occurring in the fertile window 41% of the time. Most temporal shifts 54 
(307/357, 86%) occurred on ovulation day or later. The average early-luteal phase 55 
temperature was 0.33°C higher than in the fertile window. Menstrual cycle changes in 56 
WST were impervious to lifestyle factors, like having sex, alcohol or eating prior to bed, 57 
that, in prior work, have been shown to obfuscate BBT readings. Although currently 58 
costlier than BBT, this study suggests that WST could be a promising, convenient 59 
parameter for future multi-parameter fertility-awareness methods. 60 
Keywords: Fertility awareness methods, basal body temperature, wrist skin 61 
temperature, menstrual cycle 62 
 63 
Clinical Perspectives 64 
? The present study investigates an alternative, more automatic method to 65 
traditional basal body temperature (BBT) monitoring, examining how wrist-66 
skin temperature (WST) changes across the menstrual cycle for eumenorrheic, 67 
non-pregnant women. 68 
? We observe a similar shift in wrist skin temperature around the time of 69 
ovulation and the fertile window in the majority of participants, mirroring 70 
previously noted BBT shifts. Furthermore, whereas BBT can be prone to 71 
measurement error caused by daily activities (e.g., exercising or having a big 72 
meal prior to bed), we demonstrate WST’s imperviousness to these factors.  73 
? Our findings suggest that WST could be a promising parameter for future multi-74 
parameter fertility-awareness methods. Easy to use and less invasive than oral, 75 
vaginal, or rectal BBT, wrist-worn wearables may empower users to become 76 
better attuned to their reproductive health and more readily identify phase-77 
based changes in fertility-related biomarkers across the menstrual cycle.  78 
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Introduction 79 
The biphasic basal body temperature (BBT) rhythm during the menstrual cycle 80 
has been reported and studied since the early 1900s (1), with the first observational 81 
study taking place in the 1960s (2). Defined as the core body temperature during the 82 
body’s resting state, BBT is usually estimated by measuring one’s oral, rectal, or vaginal 83 
temperature immediately upon awakening and prior to any physical activity (3). For 84 
most women, the BBT fluctuates in response to hormonal variations across the 85 
menstrual cycle. A woman’s BBT reaches its lowest point (nadir) in a given cycle 86 
around her fertile window, just prior to ovulation and corresponding to a peak in 87 
estrogen (4). Prior work suggests that sperm can survive in the female genital track for 88 
up to six days, with higher probability of conception occurring closer to ovulation (5–89 
7). Thus, we define the fertile window, or the timeframe in which conception can occur, 90 
as the five days leading up to ovulation and the day of ovulation itself. The probability 91 
of conception again drops sharply after ovulation, suggesting oocytes can only survive 92 
for twelve to twenty-four hours without fertilization (6,8–10). Thus, a dip in BBT may 93 
indicate imminent ovulation; after ovulation occurs, a woman’s BBT typically increases 94 
as progesterone levels rise (11,12). BBT constitutes a retrospective indication of the 95 
fertile window, as one cannot identify a cycle’s nadir until the subsequent post-96 
ovulation temperature rise (13). 97 
Prior research suggests that reproductive hormones are largely responsible for 98 
this biphasic shift in temperature. Estrogen, progesterone, and testosterone act 99 
directly on the warm-sensitive and cold-sensitive neurons of the preoptic anterior 100 
hypothalamus (14,15), pointing to their involvement in thermoregulation. Further, 101 
multiple studies have demonstrated that estrogen lowers the core body temperature 102 
(16–20); it, along with testosterone, both inhibit the body’s heat-retaining mechanisms 103 
and accelerate the body’s heat-loss mechanisms. In contrast, progesterone has the 104 
opposite chemical effect, thus increasing BBT post-ovulation (15,18).  105 
Tracking one’s BBT as a means of natural family planning appeals to many 106 
women.  The start-up cost for participating has been historically cheap, requiring the 107 
only the purchase of an thermometer (21,22). A woman then takes her temperature 108 
each morning upon waking, recording it either electronically with an app or by hand 109 
on graph paper so that, for a given cycle, she has a chart of how her temperature has 110 
changed over time. Ideally, her temperature is taken at the same time everyday so as 111 
to minimize unintended variance due to circadian temperature shifts (23–25). In 112 
clinical settings, BBT users are often encouraged to follow the “three over six” rule to 113 
determine the start of their fertile window (2); the three over six rule suggests an 114 
upwards trend in temperature when, for the first time in a given cycle, three 115 
consecutive daily readings are higher than the six preceding daily temperatures (2,26). 116 
Some practitioners will still count this as the start of the fertile window if only 5 of the 117 
6 preceding days are lower in temperature (27). Although not an exact indicator of 118 
ovulation (28), upward shifts in BBT align with a woman’s periovulatory and fertile 119 
window in most cycles (21,22,29). The relative low cost of BBT and the ability to take 120 
one’s temperature at home may attract many women to BBT as a fertility tracking 121 
method. 122 
While BBT requires little financial investment, its accuracy depends largely on 123 
dependable usage and remains open to interpretation error. As many researchers have 124 
noted, traditional BBT measurement cannot prospectively predict a woman’s fertile 125 
window; it can only indicate retrospectively whether ovulation has occurred (21,30,31). 126 
Additionally, the method requires individuals accurately read and chart their 127 
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temperatures. Most women’s BBT shifts only 0.28 to 0.56˚C (22,30); thus, accurate 128 
measurement requires a sensitive thermometer. Reading one’s graph provides another 129 
opportunity to introduce unwanted bias into the process.  If patients misinterpret their 130 
chart, they may wrongly identify their fertile window and thus reduce the method’s 131 
efficacy (30,31). For this reason, it is recommended that women or couples interested 132 
in BBT attend training at a physician’s office (22). Environmental factors, including 133 
sleeping in late, traveling across time zones, or alcohol consumption, can affect one’s 134 
BBT, creating additional unaccounted for variance in temperature fluctuations (30). 135 
Finally, BBT may prove inconvenient for some women (21); it requires a high level of 136 
patient compliance (22), with women having to wake up at the same time daily and 137 
meticulously chart their temperatures. Failure to do so can decrease the woman’s 138 
ability to correctly identify a biphasic shift in BBT when it occurs (32). 139 
Alternative fertility testing methods 140 
BBT does not constitute the only method for determining the fertile window, 141 
however.  Some women opt instead to use at-home urine luteinizing hormone (LH) 142 
kits. Another hormone that varies across the menstrual cycle, LH rises sharply in most 143 
women anywhere from 16 to 48 hours prior to ovulation (21). This increase in LH can 144 
be detected in urine samples; specifically, LH test strips contain antibodies that bind 145 
to any LH molecules present in the urine. When the level of urinary LH is high enough, 146 
these binded complexes lead the test strip to change color (22). LH test kits range in 147 
simplicity, from single strips where users have to interpret the darkness of the LH 148 
presence line vis-à-vis a control line (e.g., Wondfo strips) to digital readers which, 149 
when fed the test strip, will indicate electronically ovulation status (e.g., ClearBlue 150 
Digital Ovulation kit).  Women using the LH method often begin testing their urine on 151 
day 6 of their menstrual cycle and will continue to test for 5-9 days or until obtaining 152 
a positive indication of ovulation (33).   153 
LH test kits present several potential advantages over BBT. Firstly, they 154 
constitute a prospective measure of the fertile window; because they can detect the rise 155 
in LH prior to ovulation, obtaining a positive LH test results allows a woman to know 156 
that she has 2-3 days of her fertile window left (21). Secondly, LH testing is noninvasive 157 
and highly accurate with digital readers rendering the interpretation of the fertile 158 
window less prone to human error (22). Whereas the BBT nadir aligns with the day of 159 
ovulation in only 43% of the cycles in fertile women (13), LH tests have been found to 160 
accurately predict ovulation in 90-100% of cycles (22). The test strips can be commonly 161 
found over-the-counter, with a pack of individual test strips costing only a few dollars 162 
(21,22). For some women, the method’s prospective nature and increased accuracy in 163 
identifying ovulation can make urinary LH testing a more favorable alternative to BBT. 164 
Urinary LH testing is not without its disadvantages, however. Whereas BBT 165 
thermometers constitute a onetime purchase, having to buy test strips for LH test kits 166 
may become expensive over numerous cycles (22). Furthermore, the LH surge can still 167 
be missed by women, even those who test daily (22). Additionally, even in those women 168 
who do manage to catch their LH surge, LH test kits can only indicate at most half of 169 
their fertile window; the days with the highest probability of conception often occur 170 
prior to a detectable LH surge (21,22). This could explain why, despite LH test’s greater 171 
accuracy in detecting pending ovulation, studies have shown no difference in 172 
conception rates for women using the BBT or LH test method to track fertility (34). 173 
Recent advances in technology have sought to improve upon the disadvantages 174 
of traditional BBT temping that make alternatives like LH testing more appealing. 175 
 5 
Multiple wearable devices have been developed in the past ten years, claiming that they 176 
can estimate the day of ovulation by measuring temperature at various points in the 177 
body. For example, Tempdropi, and Avaii measure skin temperature from the armpit 178 
and the wrist respectively, while Yonoiii is an eardrop with a built-in thermometer that 179 
aims to estimate core body temperature.  Less invasive than traditional thermometers, 180 
these wearable devices rest on the surface of the skin and record temperature readings 181 
every few seconds to every few minutes during sleep throughout the night. They 182 
synchronize to a phone application which then automatically records and charts a 183 
woman’s temperature, notifying her when the algorithm has detected a statistically 184 
significant upshift suggestive of the fertile window. 185 
To date, few studies have considered the accuracy of new, wearable technology 186 
in predicting BBT shifts. There is some empirical precedence to suggest skin 187 
temperature—and not just oral or rectal temperature—may fluctuate in response to 188 
changes in the menstrual phase.  Prior research, relying on skin sensors worn during a 189 
laboratory visit or at home, have shown an increase in skin temperature during the 190 
luteal phase in line with traditional BBT patterns (35). However, past studies used 191 
multiple sensors  across both waking and sleeping hours; to date, none have considered 192 
whether wrist skin temperature (WST) measured during sleep alone can adequately 193 
predict menstrual phase changes.  194 
With current technology, we can now empirically address many of the 195 
disadvantages affecting traditional BBT compliance and accuracy. Continuous 196 
recording of WST, for example, provides a more robust method of estimating body 197 
temperature in comparison to BBT and other methods depending on self-198 
measurement (35). We propose conducting these measurements during sleep to 199 
capture the complete resting state and the minimum core body temperature known to 200 
occur then (3,36–40). Moreover, how WST correlates with the different phases of the 201 
menstrual cycle has not been yet elucidated. Furthermore, we examine how factors 202 
known to confound BBT measurements affect WST. If shown to be accurate, wrist 203 
wearable temperature sensors could comprise a reliable, user-friendly, and non-204 
invasive alternative to traditional BBT (3,32–36). 205 
Aim of the present study 206 
The aim of the present study is to evaluate whether WST patterns correlate with 207 
the different phases of the menstrual cycle when measured continuously during sleep. 208 
In addition, we will examine the agreement between urine ovulation detection kits and 209 
classical BBT methods applied to WST. Finally, we evaluate whether WST is 210 
impervious to environmental factors known to skew traditional BBT measurements. 211 
Material and methods 212 
Participants 213 
One hundred and ninety-four participants were recruited for an observational 214 
clinical study at the Department of Reproductive Endocrinology at the University 215 
                                                   
i Temprdrop Ltd, Hata’asiya 11 (Hubanana Hub), Ra’anana, 43656, Israel (http://tempdrop.xyz/) 
ii Ava AG, Räffelstrasse 26, 8045 Zurich, Switzerland (http://www.avawomen.com/) 
iii YONO Health Inc., 4500 Great America PKWY #1038, Santa Clara, CA 95054, U.S.A. (https://www.yonolabs.com/) 
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Hospital Zurich, Switzerland. To be invited to participate in the study, women could 216 
not: be pregnant; have any known health-related issues; be taking medications known 217 
to affect the menstrual cycle; frequently fly across time zones; or have sleeping 218 
disorders. Further inclusion criteria were: are between 20-40 years; and regular 219 
menstrual cycles (self-reported length between 24-36 days). All study participants 220 
signed written informed consent. The ethical commission of the canton of Zurich, 221 
Switzerland approved the study protocol (approval number: KEK 170404), and the 222 
study was conducted accordingly. 223 
Study protocol 224 
The participants measured their temperature nightly during sleep using the Ava 225 
bracelet (Ava AG, Zürich, Switzerland), registered with the United States Food and 226 
Drug Administration as a fertility aid device. The Ava bracelet measures several 227 
physiological parameters including WST. Study participants were instructed to wear 228 
the bracelet on the dorsal side of the wrist while sleeping and on the same arm for the 229 
study’s duration.  230 
Ovulation day (OV) was estimated using a urine luteinizing hormone (LH) 231 
home-ovulation test (Clearblue Digital Ovulation Kit), which has been shown to have 232 
high concordance with ultrasound determination of ovulation (90-100% accurate;  233 
(41). Beginning five days after the onset of menses and extending through confirmed 234 
ovulation, women were requested to perform the LH test each morning at home. The 235 
LH test shows a smiling face indicating “peak fertility”, which in turn corresponds to 236 
OV-1 in most cases (42). All participants were instructed on the usage of the tests by a 237 
trained nurse.  238 
In addition to urinary tests and wearing the temperature-tracking bracelet 239 
nightly, participants also completed daily electronic diaries related to their activities 240 
and food consumption. Prior research on BBT tracking using traditional methods has 241 
found that consuming meals (43,44), drinking coffee (42), drinking alcohol (45), 242 
engaging in sexual intercourse or heavy exercise (46) in the three hours preceding sleep 243 
can significantly affect next-morning’s BBT; these confounders may mask or obscure 244 
temporal shifts caused by the menstrual cycle and of primary interest to the user. To 245 
test these activities effects on WST, we had women record their participation or 246 
consumption in their daily diaries. In addition to the above factors, women also 247 
reported spotting (defined as any bleeding occurring outside the menstrual phase). A 248 
more detailed description of the covariates and their measurement units can be found 249 
in our previously published paper (47,48), which shares similar methodology but a 250 
different outcome of interest. 251 
The different phases of the menstrual cycle were labeled as follows: the 252 
menstrual phase, beginning with menses and lasting five days; the follicular 253 
phase, beginning with the first day post-menses and lasting through OV -6; the 254 
fertile phase, beginning with OV -5 and lasting through OV; the early-luteal 255 
phase, beginning with OV +1 and lasting through OV +7;  and, the late-luteal phase, 256 
beginning with OV +8 and lasting through the day prior to menses’ onset.  257 
Data collection and data processing 258 
All data processing and analysis were performed in R (v3.3.1) and Python 3.5. 259 
The Ava bracelet continuously records WST, providing one measurement every ten 260 
seconds. To avoid variation induced by the initial drop in body temperature at the onset 261 
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of sleep and subsequent rise prior to waking (49,50), the first 90 and the last 30 262 
minutes of each night’s data were excluded. Consistent with best practices in 263 
nonparametric modeling and to remove artificial fluctuations due to the measurement 264 
tool (51,52), temperature data were LOESS smoothed before statistical analysis. The 265 
99th (stable maxima) was chosen out of several percentiles (10, 50, 90%) to assess the 266 
correlation of WST with the different menstrual phases. There was no significant 267 
difference in a mixed effects model fit comparing data from the 99th percentile to data 268 
from the 50th or 90th percentiles, as assessed by pairwise log-likelihood tests (all p’s> 269 
0.05).  The data from the 99th percentile was a significantly better fit than data from 270 
the 10th percentile (?????? ? ?????? ? ? ??????); thus, we chose to analyze the former 271 
percentile. 272 
Consistent with the three over six rule’s underlying theory, we marked a shift in 273 
skin temperature when a woman’s WST rose at least 0.2°C above at least 5 of the 274 
preceding 6 days and stayed elevated for a minimum of 3 consecutive days (51,53,54). 275 
Such an upward shift is useful in retrospectively confirming the occurrence of 276 
ovulation and the potential end of the fertile window. As temperature nadir was 277 
demonstrated in past BBT studies to be a prospective marker of ovulation (55), we also 278 
analyzed our WST results to see if a similar minimum temperature occurred 279 
approximating ovulation.  280 
We used linear mixed effects models with random intercepts and random slopes 281 
to assess the association between WST and menstrual phases. Such models allow for 282 
the modeling of repeated measurements, accounting for correlated intra-individual 283 
and intra-cycle observations (56). Because most participants reported multiple cycles 284 
and each cycle had its own phase shift, we analyzed our data using cross-classified 285 
models; we specified that cycle numbers were nested within individual and the phases 286 
were nested within a cycle.  Potential covariates previously shown to impact BBT were 287 
collected from participants’ daily diary reports and assessed for their effect on WST 288 
across the menstrual cycle using similar multi-level, cross-classified models as 289 
described above. Significant covariates were included in the final multivariate multi-290 
level model based on previously reported or potential clinical and practical relevance. 291 
Where appropriate, mean WST and its standard deviation are reported in text. For 292 
each model, unstandardized b-coefficients and their standard errors are reported in 293 
Table 1, 2, or 3.  294 
Results 295 
Descriptive statistics of the study population 296 
Overall, 793 menstrual cycles were recorded across 194 study participants. In 297 
keeping with recommendations for best performance in fertility prediction algorithms 298 
(30,42–45), we excluded data from 186 cycles where participants reported 299 
measurements and synchronized their WST to the app less than 80% of the days 300 
between the fertile window and the early luteal phase. This left a reduced sample of 301 
603 cycles across 159 participants. We also restricted our sample to participants with 302 
a confirmed ovulation, as detected via LH test; while an interesting extension of 303 
wearable technology, tracking potential anovulatory cycles is beyond the scope of the 304 
current study. Removing 170 cycles without confirmed LH surges left us with a final 305 
sample of 437 cycles across 136 participants; the average number of cycles per user in 306 
our sample was 3.21 (S.D.=2.25). Participants had an average age of 33.66 (S.D.=3.86) 307 
and an average BMI of 22.97kg/m2 (S.D.=3.68). The average cycle length for the final 308 
sample was 28.84 days (S.D.=7.02).  309 
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Skin temperature rhythm during the menstrual cycle  310 
We detected a shift in skin temperature in 82% of the cycles. The majority of 311 
detected temperature shifts (86%) took place on or after the ovulation day (Figure 1). 312 
The choice of threshold at which the temperature shift occurred altered the 313 
aforementioned numbers minimally (e.g., setting the temperature threshold at 0.15°C 314 
yields 88% and 84% respectively). None of the participants had exclusively 315 
monophasic temperature patterns nor temperature shifts occurring exclusively before 316 
ovulation (for participants with more than one cycle).  317 
Occurring mostly prior to ovulation, the lowest temperature  in a given cycle was 318 
often observed outside the fertile window. Only in 41% of the 357 cycles was the nadir 319 
detected within the fertile window (OV-5 to OV; see Figure 2).  Twelve percent of cycles 320 
showed a WST nadir occurring after ovulation, while the remaining 47% had the lowest 321 
WST reading prior to the fertile window.  In sum, the majority (88%) of the biphasic 322 
cycles in our study exhibited a WST nadir prior to ovulation.  323 
Quantification of The Change in Skin Temperature Across the Menstrual 324 
Phases 325 
Consistent with our hypothesis and patterns in traditional BBT tracking, 326 
average WST during the menstrual phase (M=35.32˚C, S.D.=0.71) was significantly 327 
lower than the average WST during the early-luteal (M=36.04˚C, S.D.=0.69; 328 
t(4.05)=10.53, P<.001) and late-luteal phases (M=35.70˚C, S.D.=0.63; t(3.83)=12.37, 329 
P<.001). In addition, women had significantly lower WST (M=35.23 ˚C, S.D.=0.67), 330 
on average, in their fertile phase compared to their menstrual phase WST (see Table 331 
1). 332 
Influence of BBT-documented covariates on WST 333 
Whereas prior research has found BBT readings and temperature shifts can be 334 
skewed by environmental factors (11,51,53,57–59), our findings suggest WST is robust 335 
to these confounders. For each covariate, we ran a separate multivariate, multi-level 336 
model predicting temperature in the 99th percentile based off phase and that covariate.  337 
The main effects of phase shift describe above remained significant, even when 338 
controlling for covariates. Spotting, age, and having coffee or exercising in the three 339 
hours preceding sleep did not significantly affect WST (see Table 2).  Although a 340 
woman with a higher BMI was significantly more likely to have a lower WST, the 341 
direction and magnitude of menstrual phase shifts on WST remains unchanged. 342 
Having sex and eating a large meal in the 3 hours before bed were also significantly 343 
associated with increases in nightly WST; however, the effect of menstrual phase on 344 
WST remained significant. Finally, the effect of the menstrual cycle on WST was 345 
significant even when controlling for drinking 5 or more units up to three hours before 346 
bed. For the full model statistics, please see Table 2.   347 
Finally, we entered all the significant covariates into a full model with phase 348 
effects to further ensure the robustness of our hypothesis. As before, WSTs in the early- 349 
and late-luteal phases were significantly higher than WST in the menstrual phase, over 350 
and above the effects of any potential covariates (see Table 3). Our findings suggest 351 
biphasic shifts in WST across the menstrual cycle are detectable regardless of 352 
individual behavior or activities prior to sleep, a marked difference from potential 353 
confounds plaguing traditional BBT readings. 354 
Discussion 355 
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In this study, a biphasic skin temperature pattern was identified in 82% of 356 
cycles. In addition, the nadir skin temperature did not provide a robust prospective 357 
estimation of ovulation. We observed the utility of the skin temperature as a 358 
retrospective confirmatory marker for ovulation in 86% of the cycles where a biphasic 359 
pattern was observed. Finally, we observed the robustness of wrist skin temperature 360 
measurements to environmental factors, including alcohol, coffee, exercise, food, and 361 
sex. 362 
Our findings are consistent with evidence from traditional BBT studies, 363 
suggesting wrist temperature measurements tap into the same underlying mechanism. 364 
The occurrence of a monophasic, temperature pattern in ovulatory cycles in 18% of the 365 
regular ovulatory cycles corresponds to the range (0-20%) found in other studies that 366 
confirm ovulation via serum hormonal levels, ultrasound, or pregnancy (11,51,53,57–367 
59). In our study, the proportion of cycles with retrospective ovulation confirmation by 368 
virtue of a temperature shift matches those of earlier BBT studies (22,30). 369 
Furthermore, the magnitude of the observed temperature shift in our study 370 
(?????????????????????????????????? ? ??????? falls within the observed range (0.28?? - 0.56??) 371 
seen in classical BBT studies (11,51,59,60). Finally, the range of days in which the shift 372 
can occur varied broadly for both this study and previous studies (51,53,54).  373 
The BBT nadir is reported to be indicative of the ovulation day and has been 374 
identified within one day of ovulation in 33-75% of the cycles in prior studies (61). In 375 
this study, a nadir was identified in 41% of the cycles within the fertile window. 376 
Although seemingly low, it is not inconsistent with the variability of BBT nadirs found 377 
in prior studies, with temperature shifts occurring as early as 8 days prior to and 4 days 378 
post ovulation (11). BBT nadirs have been found to differ from LH peaks in 55-70% of 379 
cycles (62,63). While the initial rise in progesterone levels has been shown to occur 380 
consistently around ovulation and almost never earlier than a day before ovulation, 381 
estrogen levels are much more variable (64). This could explain the more consistent 382 
observation regarding temperature elevation (associated with progesterone rise) and 383 
much less consistently the temperature decrease (associated with estrogen rise).  384 
Although we estimated ovulation’s occurrence via an at home LH tests, we did 385 
not confirm it in-lab via reproductive hormone levels or an ultrasound. The number of 386 
cycles with a monophasic pattern might be due to: (a) a false positive urine LH test; (b) 387 
misinterpretation or non-compliance of the user; or, (c) no (detected) shift in wrist skin 388 
temperature despite ovulation. We excluded 170 cycles out of 793 total (21%) due to no 389 
user-confirmed LH peak. This could hint towards user compliance issues with home 390 
urine tests, misuse of the device, unreliable monitors, or insufficient hormonal 391 
variation due to health conditions (33). Aside from an ultrasound, currently there are 392 
no consensus on the biomarkers for anovulation. The hormonal profile that constitutes 393 
an anovulatory cycle remains disputable, and the algorithms employed give varying 394 
rates of anovulatory cycles (3-19%; 65). A false positive rate remains an open point for 395 
future research with ultrasound verification of ovulation as a reference. 396 
One of the strengths of the skin temperature method using a wearable device 397 
compared to the oral, vaginal, or rectal BBT method is the continuous measurement 398 
during the night and the ease of providing automatic detection of the shift by computer 399 
programs or smartphone applications (e.g. cycle tracking applications). This renders 400 
the measurements less susceptible to measurement errors (e.g. different waking time) 401 
and misinterpretation of the results. Similar to other wearables measuring 402 
physiological parameters, the device used in this study requires the user to sync it to 403 
the phone application. We excluded data from 186 cycles in our study due to user non-404 
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compliance on 20% of the days in a given cycle (e.g., not syncing 6 days out of a 28 day 405 
cycle); it is conceivable that this compliance issue could decrease or increase in the 406 
general population depending on the device used to measure WST (e.g., one would 407 
expect the compliance to increase if the device were to automatically sync once wireless 408 
internet or a Bluetooth connection is available without the user’s involvement). In this 409 
study the individuals were required to measure LH using urine tests, fill in a daily 410 
survey, and they were blind to the measurement of the device. It is plausible that in the 411 
real-world scenarios observing the daily progression of the physiological parameters 412 
and predictions would motivate the user for further compliance. Other current 413 
methods of fertility tracking are not impervious to similar limitations. Women who do 414 
not take their BBT measurements at precisely the same time daily or who miss several 415 
days in a given cycle may less easily detect a biphasic temperature shift (22). Similarly, 416 
women using LH tests who skip a day of urinary testing run the risk of missing the only 417 
indication of a LH surge and impending ovulation (33). Thus, it remains an empirical 418 
question for future studies whether women would have greater compliance using a 419 
less-invasive method like WST than using LH testing or traditional BBT.  420 
On a related note, future studies may also consider whether users find WST 421 
fertility tracking less burdensome and inconvenient than BBT. Traditional BBT 422 
methods require women wake up several hours before rise to take their temperature 423 
(21).  Indeed, when asked about the burden associated with BBT methods, most women 424 
in a prior study found the method cumbersome; only 15% of patients described BBT 425 
procedure as having “no burden” (53). Because wearable devices, like the one used in 426 
our study, measure WST continuously throughout the night, they alleviate the need for 427 
users to wake up early.  It follows then that they may be perceived by users as being 428 
less burdensome and/or more convenient.  However, this is an empirical question and 429 
one that remains to be tested.  It may be that the need to sync the device with a phone 430 
daily proves similarly burdensome as taking one’s vaginal, oral, or rectal temperature 431 
daily.  Future studies could improve upon our findings, by exploring the potential ease 432 
of use and convenience that WST may offer over traditional BBT fertility tracking.   433 
 A second novel strength of wrist-based skin temperature measurement in 434 
fertility tracking appears to be its imperviousness to environmental factors. We show 435 
that wrist-based wearables are sensitive enough to pick up phase-based shifts in 436 
temperature, over and above any changes that may be due to having sex, food or 437 
alcohol consumption. This presents an advancement in fertility awareness 438 
temperature tracking, allowing women increased accuracy in ovulation prediction 439 
without having to change pre-bedtime habits.   440 
Ovulation tracking methods currently cost from ten to several hundred 441 
American dollars, depending on the underlying technology (22). The calendar and BBT 442 
methods represent the lower spectrum of this price range while multi-parameter 443 
devices (such as the one employed in this study) and digital Estrogen/LH measuring 444 
devices occupy the upper range. Each of the mentioned methods have advantages and 445 
disadvantages in terms of cost, convenience, being prospective, and accuracy. Further 446 
studies comparing current methods on the market will aid the user to decide which of 447 
these methods offer a compelling case for their needs.  448 
In addition to being reusable, multi-parameter devices may also offer women 449 
insight into more of their fertile days than OPKs (46,66). Although OPKs can 450 
prospectively predict the fertile window (21,22), they provide only a 12-48 hour 451 
advanced notice that ovulation may be about to occur (21). Multi-parameter devices 452 
have the potential to prospectively predict more of the fertile days (46,66).  While the 453 
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current study examined the confirmatory presence of a shift in WST over the fertile 454 
window, when paired with more physiological parameters (e.g., pulse rate (46)) and 455 
more sophisticated statistical methods (e.g., machine-learning), devices measuring 456 
multi physiological parameters can learn an individual woman’s typical cycle 457 
physiological variation and use that to detect more of her fertile days. Furthermore, 458 
this information can be made easily readable and available via a phone application. 459 
This technology could be combined with OPKs for further tuning. For example, the 460 
application would indicate the approach of the fertile window, allowing women to 461 
better predict when to begin urinary LH testing. Using both methods together, women 462 
could better identify the highest fertility days (missed by LH testing alone) and confirm 463 
that ovulation took place. Combining fertility awareness methods is widely seen as the 464 
most effective way to track fertility, with numerous researchers suggesting 465 
incorporating newer technological advances to better identify the full fertile window 466 
(22,67,68). Future studies should explore the successful conception rates of WST 467 
devices used in conjunction with other methods; it may be that this technological 468 
advance on traditional BBT provides the prospective window necessary to take 469 
advantage of the highest fertile days. 470 
Conclusion 471 
In this study, we demonstrated that the rhythm of skin temperature during 472 
menstrual cycle as measured by a wrist worn wearable shows a biphasic pattern in 82% 473 
of the cycles, which is comparable to the results obtained in prior studies using BBT. 474 
Consequently, daily skin temperature measurements taken during the night with 475 
today’s wearable sensor technology could be a potential alternative for the oral, rectal, 476 
or vaginal BBT method. However, by itself, and in agreement with the BBT method, 477 
WST did not capture all ovulation events, and majorly, retrospectively. Therefore, skin 478 
temperature could be a potentially useful parameter to be combined with other 479 
physiological measurements correlating with the onset of the fertile window and with 480 
ovulation for a more comprehensive modern fertility awareness method. 481 
 482 
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Figure 1. A histogram of the percentage of temperature shifts occurring on 663 
a given day with reference to home LH test (n=307).  664 
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Figure 2. A histogram of the percentage of days on which the lowest 667 
temperature was observed in a given cycle with reference to home LH test 668 
(n=307).  669 
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